Aprea Therapeutics Inc (NASDAQ:APRE) The last few days the stock has seen increased volume and price. From a technical standpoint, the stock looks to have bottomed. It broke the falling wedge pattern and could eventually rally up to test its 100-day EMA in the coming days. In addition, MACD, RSI and ADX also indicate positive momentum. To think APRE was trading at $8.4 not long ago. This is worth watching and possibly stepping in for a trade.